the world's headlines, one feed
Massachusetts biotech Scholar Rock said it's pulling an embattled Indiana-based manufacturing site from its application for a potential new spinal muscular atrophy drug, after the site was again cited for deficiencies by the FDA following ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Mumbai: The Maharashtra Food and Drug Administration (FDA) has suspended the food licence of Blink Commerce Private Limited in Malad (West) after an inspection found severe hygiene lapses, a major…
The United Nations Educational, Scientific and Cultural Organization, UNESCO, has sensitised no fewer than 5,000 corps members serving in Ogun State on Sexual and Reproductive Health Rights, SRHR, HIV…
The rule would close a decades-old gap that let manufacturers add ingredients to food without alerting federal regulators
Researchers say the oral drug LM11A-31 slowed the decline of brain-network function in a small trial, pointing to a potential broader strategy for treating Alzheimer’s.
As gambling becomes more accessible to college students, a statewide study of Mississippi's public universities found gambling problems frequently occur alongside depression, anxiety and substance…
Researchers have identified genetic changes in malaria parasites that may reduce the effectiveness of key antimalarial medicines, highlighting the need for continued surveillance.